SGHT - Sight Sciences, Inc.

QQQ $ 604.97 $ -5.86 (-0.96 %)

DIA $ 467.52 $ -1.70 (-0.36 %)

SPY $ 667.78 $ -4.14 (-0.62 %)

TLT $ 91.94 $ -0.04 (-0.05 %)

GLD $ 370.60 $ -2.27 (-0.61 %)

Previous Close

$ 5.16

Open

$ 5.20

Bid

$ 5.00 x 423

Ask

$ 5.02 x 400

Day's Range

$ 4.91 - $ 5.20

52 Week Range

$ 2.03 - $ 5.71

Volume

262,093

Average Volume

Market Cap

270.22M

Beta (5Y Monthly)

$ 1.77

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	08-07-2025	06-30-2025	10-Q
2	05-08-2025	03-31-2025	10-Q
3	03-07-2025	01-01-1970	10-K
4	11-07-2024	09-30-2024	10-Q
5	08-02-2024	06-30-2024	10-Q
6	05-06-2024	03-31-2024	10-Q
7	03-12-2024	12-31-2023	10-K
8	11-07-2023	09-30-2023	10-Q
9	08-07-2023	06-30-2023	10-Q
10	05-08-2023	03-31-2023	10-Q
11	03-16-2023	12-31-2022	10-K
12	11-10-2022	09-30-2022	10-Q
13	08-11-2022	06-30-2022	10-Q
14	05-10-2022	03-31-2022	10-Q
15	03-24-2022	12-31-2021	10-K
16	11-10-2021	09-30-2021	10-Q
17	08-12-2021	06-30-2021	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Lake Street Maintains Buy on Sight Science...
10/21/2025 14:56:03

Lake Street analyst Frank Takkinen maintains Sight Sciences (NASDAQ:SGHT) with a Buy and raises the price target from $5 to $7.

12 Health Care Stocks Moving In Friday's I...
10/17/2025 17:05:58

Sight Sciences Secures Medicare Pricing Fo...
10/17/2025 11:03:39

Sight Sciences, Inc. (NASDAQ:SGHT) (Sight Sciences or the Company), an eyecare technology company focused on developing and com...

Citigroup Maintains Neutral on Sight Scien...
10/07/2025 17:48:36

Citigroup analyst Joanne Wuensch maintains Sight Sciences (NASDAQ:SGHT) with a Neutral and lowers the price target from $4.5...

Sight Sciences Highlights Meta-Analysis Of...
09/17/2025 11:11:50

unitedhealthcare-adds-sight-sciences-omni-system-to-covered-glaucoma-surgery-procedures

UnitedHealthcare Adds Sight Sciences OMNI ...
09/09/2025 15:39:52

UnitedHealthcare's new policy covers implant-free glaucoma surgeries like OMNI, supporting treatment for mild to moderate o...

Sight Sciences' OMNI Surgical System To Be...
09/09/2025 11:07:22

Sight Sciences Publishes Dry Eye Workshop ...
09/02/2025 20:07:12

Needham Reiterates Hold on Sight Sciencest...
08/28/2025 16:44:29

Needham analyst David Saxon reiterates Sight Sciences (NASDAQ:SGHT) from Hold to Hold.

What 4 Analyst Ratings Have To Say About S...
08/21/2025 19:00:41

Citigroup Maintains Neutral on Sight Scien...
08/21/2025 18:14:30

Citigroup analyst Joanne Wuensch maintains Sight Sciences (NASDAQ:SGHT) with a Neutral and raises the price target from $3.6...

Lake Street Upgrades Sight Sciences to Buy...
08/08/2025 22:18:39

Lake Street analyst Frank Takkinen upgrades Sight Sciences (NASDAQ:SGHT) from Hold to Buy and raises the price target from $...

Sight Sciences Raises FY2025 Sales Guidanc...
08/07/2025 20:16:39

Sight Sciences (NASDAQ:SGHT) raises FY2025 sales outlook from $70.000 million-$75.000 million to $72.000 million-$76.000 millio...

Sight Sciences Q2 EPS $(0.23) Beats $(0.29...
08/07/2025 20:09:02

Sight Sciences (NASDAQ:SGHT) reported quarterly losses of $(0.23) per share which beat the analyst consensus estimate of $(0.29...

Earnings Scheduled For August 7, 2025
08/07/2025 08:33:15

Sight Sciences Study Finds TearCare More E...
07/30/2025 11:13:01

Sight Sciences, Inc. (NASDAQ:SGHT) (Sight Sciences or the Company), an eyecare technology company focused on developing and com...

Sight Sciences Unveils 24-Month SAHARA RCT...
07/29/2025 11:11:00

The Analyst Verdict: Sight Sciences In The...
07/15/2025 19:00:50

Morgan Stanley Maintains Equal-Weight on S...
07/15/2025 13:13:01

Morgan Stanley analyst Cecilia Furlong maintains Sight Sciences (NASDAQ:SGHT) with a Equal-Weight and raises the price targe...

Piper Sandler Maintains Neutral on Sight S...
06/18/2025 15:21:48

Piper Sandler analyst Adam Maeder maintains Sight Sciences (NASDAQ:SGHT) with a Neutral and raises the price target from $3....